Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 December 2024 : Editorial  

Editorial: The 2024 Revision of the Declaration of Helsinki and its Continued Role as a Code of Ethics to Guide Medical Research

Dinah V. Parums1E*

DOI: 10.12659/MSM.947428

Med Sci Monit 2024; 30:e947428

Table 1 Summary of key revisions to the 2024 Declaration of Helsinki [1].

Revision to the Declaration documentDescription of the revision
TerminologyThe term ‘participants’ has replaced ‘subjects’ throughout the Declaration document, and gender-neutral language has been adopted to respect individuals involved in research
Research inclusivityThe Declaration document now addresses all individuals, teams, and organizations involved in medical research, including physicians, as an acknowledgment of the interdisciplinary nature of modern research studies and the ethical requirements of all research participants
Engagement of study participantsThe new Declaration document emphasizes meaningful engagement with research study participants before, during, and after the study has been undertaken
Recognition of participant vulnerabilityResearchers are advised to consider the long-term and global benefits, risks, and safety of research studies and the fair and responsible inclusion of vulnerable populations who require adequate support. Vulnerable individuals include those who may be unable to provide consent
Participant data and biobankingParagraph 32 of the Declaration document has been rewritten to address informed consent requirements for collecting, storing, and secondary use of data and biological materials. Situations are recognized where obtaining consent for unforeseen secondary research may not be possible, and in these cases, an Ethics Committee review and approval are required
Governance of Biobanks and Health Databases (Declaration of Taipei)The revised Declaration document cross-references the WMA Declaration of Taipei [], which provides guidelines on the governance of biobanks and health databases, including data collected for multiple and indefinite use16
Public health emergenciesA new paragraph has been added to the Declaration document that mandates that ethical principles must be upheld even during public health emergencies
Unproven or non-evidence-based interventionsRevisions to the new Declaration document clarify that unproven interventions to alleviate pain or suffering must not bypass ethical safety measures or evade evaluation by controlled clinical trials
Study design and environmental sustainabilityThe new Declaration document strengthens environmental sustainability commitments, and highlights the importance of rigorous study design to prevent wasteful research methods
The role of Ethics CommitteesThe new Declaration document recommends that sufficient resources be available to ensure the independence of research Ethics Committees to oversee research practices
Participant language, preferences and values, and consentStudy participant language, values, and preferences should be considered when they give consent or when consent is obtained from a legally authorized representative on their behalf

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750